Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
Zentalis Pharmaceuticals, Inc. Common Stock logo

Zentalis Pharmaceuticals, Inc. Common Stock Share Price

NASDAQ: ZNTLHealthcare

$2.54

+0.01 (0.40%)
BUYSELL

Live Zentalis Pharmaceuticals, Inc. Common Stock Share Price Chart

O H L

Zentalis Pharmaceuticals, Inc. Common Stock Performance Overview

Days Range
▼
$2.53Low
$2.65High

Markets Today

Previous Close$2.51
Open$2.53
Volume609,814
Day's Range$2.53 - $2.65
52W Range$1.21 - $6.95
Market Cap$237.63 M

Historical Performance

1M Returns-26.46
3M Returns-45.90
6M Returns-60.06
1Y Returns+57.14
5Y Returns-96.57
10Y ReturnsNA

Zentalis Pharmaceuticals, Inc. Common Stock Fundamentals

Market Cap$237.63 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.50
EPS TTM$-1.96
Quarterly Earnings Growth YOYN/A
PB Ratio1.25
EBITDA$-144.27 M
Profit MarginN/A
Market Cap$237.63 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.50
EPS TTM$-1.96
Quarterly Earnings Growth YOYN/A
PB Ratio1.25
EBITDA$-144.27 M
Profit MarginN/A

Zentalis Pharmaceuticals, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$45.62 M-$36.06 M-$33.73 M-$37.39 M-$37.85 M-$44.39 M
EBITDA -$37.56 M-$35.90 M-$33.57 M-$37.24 M-$37.70 M-$44.24 M
Interest Expense $0$0$0$0$0$0
Depreciation $8.06 M$160.00 K$160.00 K$157.00 K$151.00 K$153.00 K
Income Before Tax -$48.28 M-$26.87 M-$26.69 M-$34.77 M-$35.23 M-$42.15 M
Income Tax Expense $0$0$0$442.00 K$120.00 K$138.00 K
Net Income +-$48.28 M-$26.87 M-$26.69 M-$35.22 M-$35.35 M-$42.29 M
Net Profit Margin ------

Zentalis Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $72.00 K$72.00 K$72.00 K$69.00 K$71.00 K$72.00 K
Reserve & Surplus -$1.10 B-$1.13 B-$1.16 B-$1.19 B-$1.23 B-$1.27 B
Non-Current Liabilities $39.21 M$38.19 M$37.21 M$36.20 M$35.15 M$34.06 M
Current Liabilities $49.43 M$39.02 M$37.17 M$36.56 M$35.24 M$37.63 M
Total Liabilities $88.64 M$77.21 M$74.38 M$72.76 M$70.39 M$71.68 M
Fixed Assets $3.25 M$3.09 M$2.93 M$2.77 M$2.65 M$2.50 M
Current Assets $342.88 M$311.60 M$288.30 M$253.19 M$218.10 M$181.28 M
Total Assets $384.02 M$351.71 M$327.25 M$288.97 M$253.07 M$215.33 M

Zentalis Pharmaceuticals, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$48.28 M-$26.87 M-$26.69 M-$35.22 M-$35.35 M-$42.29 M
Operating Cash Flow -$32.64 M-$34.71 M-$26.96 M-$30.94 M-$32.96 M-$37.24 M
Investing Cash Flow $40.48 M$30.38 M$28.32 M$32.45 M$30.01 M$30.02 M
Financing Cash Flow $189.00 K$0$115.00 K-$4.59 M-$1.12 M$65.00 K
Change in Cash $8.03 M-$4.33 M$1.47 M-$3.08 M-$4.07 M-$7.15 M

Zentalis Pharmaceuticals, Inc. Common Stock Return Calculator

The Zentalis Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$330
Invested Amount$10,000
Est. Returns$-9,670
Invest in USA Stock Today

About Zentalis Pharmaceuticals, Inc. Common Stock

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

FAQs

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) share price as of October 10, 2026 is $2.54. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Share by opening an international trading account with Angel One.
Purchasing Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Zentalis Pharmaceuticals, Inc. Common Stock on October 10, 2026, is $237.63 M.
Zentalis Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL